Novo Nordisk

The recent pullback in Novo Nordisk stock after its guidance update has put a harsh spotlight on obesity and metabolic disorder therapeutics. The market reactio...

Novo Nordisk’s Wegovy pill launched this year and has continued to show strong growth. Tom Little / Reuters Wegovy maker Novo Nordisk NOVO.B -5.79 %decrease; d...

Manipal is India’s largest private hospital group by bed capacity with nearly 50 hospitals and over 13,000 beds across the country. Priyanshu Singh / Reuters S...

Novo Nordisk's quarterly beat and guidance increase did little to resolve Wall Street's biggest concern: whether the Ozempic maker has a convincing path back to...

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Novo Nordisk’s Wegovy pill saw lower-than-expected sales that surprised investors, although it’s been held up as the most successful drug launch of all time. I...

Novo Nordisk A/S (NYSE:NVO) stock is trading lower on Tuesday despite the company raising its fiscal 2026 guidance. The weight loss drug maker reported second...

Technology Novo Nordisk Dives 6% After Unexpectedly Releasing Earnings A Day Early Licensing Novo Nordisk (NVO) stock plummeted Tuesday after the obesity kingpi...

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in Copenhagen, Denmark, March 26, 2026. U.S.-t...

Novo Nordisk (NVO) raised its full-year outlook for the second time this year, citing increased expectations for GLP-1 product sales. The Danish drugmaker now...